2cureX AB logo

2CUREX - 2cureX AB Share Price

SEK14.1 0.2  1.1%

Last Trade - 4:18pm

Sector
Healthcare
Size
Micro Cap
Market Cap £13.8m
Enterprise Value £11.1m
Revenue £n/a
Position in Universe 1177th / 1487
Bullish
Bearish
Unlock 2CUREX Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

2CUREX Revenue Unlock 2CUREX Revenue

Net Income

2CUREX Net Income Unlock 2CUREX Revenue

Normalised EPS

2CUREX Normalised EPS Unlock 2CUREX Revenue

PE Ratio Range

2CUREX PE Ratio Range Unlock 2CUREX Revenue

Dividend Yield Range

2CUREX Dividend Yield Range Unlock 2CUREX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
2CUREX EPS Forecasts Unlock 2CUREX Revenue
Profile Summary

2cureX AB is a Sweden-based company engaged in the biotechnology sector. The Company focuses on the research and development of diagnostic substances to select treatment for cancer patients. The Company's product candidate, IndiTreat - CRC, aims at optimizing medical treatment for the colorectal cancer patients. Through IndiTreat - CRC, healthcare professionals collect a tumor sample from patients to create a number of three-dimensional micro tumors in order to test available chemotherapies and experimental treatments. The Company's product pipeline includes also IndiTreat - OVA, targeting ovarian cancer treatment, and IndiTreat - KDN, focusing on kidney cancer treatment. It operates through 2cureX A/S.

Directors
Last Annual December 31st, 2018
Last Interim June 30th, 2019
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange OMX Nordic Exchange Stockholm
Shares in Issue 12,420,000
Free Float (0.0%)
Eligible for
ISAs
SIPPs
Address c/o Mazars SET Revisionsbyra AB Box 159, LANDSKRONA, 261 22, Sweden
Web https://www.2curex.com/
Phone +
Contact ()
Auditors Ohrlings PricewaterhouseCoopers AB
2CUREX Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 2CUREX
Upcoming Events for 2CUREX
Thursday 21st November, 2019 Estimate
Q3 2019 2cureX AB Earnings Release
Friday 28th February, 2020 Estimate
Q4 2019 2cureX AB Earnings Release
Similar to 2CUREX
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.